Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CIRO A CICCARELLI

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1548243579
CMS profile
24142
Location
HEWLETT, NY

General Payments · PY2018–2024

$11,940.97

  • Reported across 532 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,440.97

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,440.97 36

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,576.42 86
PY2019 $1,841.11 104
PY2020 $1,302.09 82
PY2021 $1,784.94 91
PY2022 $2,115.53 104
PY2023 $1,879.91 29
PY2024 $1,440.97 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $6.73 01/11/2024 Food and Beverage Undisputed 01/23/2026 1105746539 CMS
AstraZeneca Pharmaceuticals LP $119.98 01/31/2024 Food and Beverage Undisputed 01/23/2026 1105347719 CMS
AstraZeneca Pharmaceuticals LP $119.82 03/07/2024 Food and Beverage Undisputed 01/23/2026 1105232628 CMS
AstraZeneca Pharmaceuticals LP $66.74 09/13/2024 Food and Beverage Undisputed 01/23/2026 1105799132 CMS
AstraZeneca Pharmaceuticals LP $97.75 09/14/2024 Food and Beverage Undisputed 01/23/2026 1104560232 CMS
AstraZeneca Pharmaceuticals LP $118.73 11/12/2024 Food and Beverage Undisputed 01/23/2026 1104251843 CMS
AstraZeneca Pharmaceuticals LP $20.89 11/21/2024 Food and Beverage Undisputed 01/23/2026 1104238581 CMS
AstraZeneca Pharmaceuticals LP $125.00 12/05/2024 Food and Beverage Undisputed 01/23/2026 1105463185 CMS
Electromed, Inc. $20.57 12/12/2024 Food and Beverage Undisputed 01/23/2026 1137884238 CMS
GlaxoSmithKline, LLC. $16.75 01/25/2024 Food and Beverage Undisputed 01/23/2026 1116731806 CMS
GlaxoSmithKline, LLC. $5.00 02/14/2024 Food and Beverage Undisputed 01/23/2026 1116601467 CMS
GlaxoSmithKline, LLC. $14.24 02/21/2024 Food and Beverage Undisputed 01/23/2026 1115973369 CMS
GlaxoSmithKline, LLC. $10.55 03/01/2024 Food and Beverage Undisputed 01/23/2026 1116559589 CMS
GlaxoSmithKline, LLC. $12.75 03/27/2024 Food and Beverage Undisputed 01/23/2026 1116155136 CMS
GlaxoSmithKline, LLC. $96.47 04/02/2024 Food and Beverage Undisputed 01/23/2026 1115966618 CMS
GlaxoSmithKline, LLC. $18.25 04/30/2024 Food and Beverage Undisputed 01/23/2026 1116408099 CMS
GlaxoSmithKline, LLC. $17.60 05/01/2024 Food and Beverage Undisputed 01/23/2026 1116293037 CMS
GlaxoSmithKline, LLC. $16.85 05/17/2024 Food and Beverage Undisputed 01/23/2026 1116016456 CMS
GlaxoSmithKline, LLC. $21.83 06/07/2024 Food and Beverage Undisputed 01/23/2026 1116711439 CMS
GlaxoSmithKline, LLC. $11.80 06/25/2024 Food and Beverage Undisputed 01/23/2026 1116655329 CMS
GlaxoSmithKline, LLC. $19.10 07/01/2024 Food and Beverage Undisputed 01/23/2026 1116468028 CMS
GlaxoSmithKline, LLC. $18.52 08/02/2024 Food and Beverage Undisputed 01/23/2026 1116489858 CMS
GlaxoSmithKline, LLC. $124.32 09/13/2024 Food and Beverage Undisputed 01/23/2026 1116057993 CMS
GlaxoSmithKline, LLC. $12.87 09/19/2024 Food and Beverage Undisputed 01/23/2026 1115885732 CMS
GlaxoSmithKline, LLC. $14.92 10/16/2024 Food and Beverage Undisputed 01/23/2026 1116287208 CMS
GlaxoSmithKline, LLC. $21.03 11/14/2024 Food and Beverage Undisputed 01/23/2026 1116564982 CMS
GlaxoSmithKline, LLC. $124.95 11/19/2024 Food and Beverage Undisputed 01/23/2026 1115820952 CMS
GlaxoSmithKline, LLC. $16.36 11/27/2024 Food and Beverage Undisputed 01/23/2026 1116318736 CMS
GlaxoSmithKline, LLC. $16.41 12/20/2024 Food and Beverage Undisputed 01/23/2026 1116364823 CMS
Grifols USA, LLC $17.11 02/06/2024 Food and Beverage Undisputed 01/23/2026 1124740660 CMS
Grifols USA, LLC $24.07 04/05/2024 Food and Beverage Undisputed 01/23/2026 1124740658 CMS
Mylan Specialty L.P. $16.94 08/09/2024 Food and Beverage Undisputed 01/23/2026 1147284186 CMS
Mylan Specialty L.P. $23.90 11/08/2024 Food and Beverage Undisputed 01/23/2026 1147362524 CMS
Philips North America LLC $13.10 10/17/2024 Food and Beverage Undisputed 01/23/2026 1146877211 CMS
Philips North America LLC $14.40 12/06/2024 Food and Beverage Undisputed 01/23/2026 1146877209 CMS
Regeneron Healthcare Solutions, Inc. $24.67 12/13/2024 Food and Beverage Undisputed 01/23/2026 1114026194 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.